Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03394690
Other study ID # 911
Secondary ID
Status Recruiting
Phase N/A
First received December 26, 2017
Last updated January 3, 2018
Start date March 12, 2018
Est. completion date August 12, 2019

Study information

Verified date December 2017
Source National Nutrition and Food Technology Institute
Contact Ehsan Hejazi, PhD
Phone +98-21-22077424
Email ehsanhejazi@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study the effects of green coffee supplement on leptin, adiponectin, ghrelin, anthropometric measurements, lipid profile in breast cancer survivors.50 breast cancer survivors who their treatment is over and referred to follow breast cancer clinic with will be randomly allocated to receive placebos or 2 capsules green coffe for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, leptin, adiponectin, ghrelin, anthropometric measurements, lipid profile will be assessed and compared between groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date August 12, 2019
Est. primary completion date February 12, 2019
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- Age of 18 to 70 years

- Body Mass Index (BMI) between 25-40 treatment is over

Exclusion Criteria:

- -Taking any kind of supplement for weight reduction

- pregnancy or lactation

- Professional athletes

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
green coffee
2 capsuls
Other:
control
2 capsuls

Locations

Country Name City State
Iran, Islamic Republic of National Nutrition and Food Technology Research Institute Tehran

Sponsors (1)

Lead Sponsor Collaborator
National Nutrition and Food Technology Institute

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary gherlin assed by elisa 12 weeks
Primary Adiponectin assed by elisa 12 weeks
Primary Leptin assed by elisa 12 weeks
Secondary body mass index The body mass index (BMI) or Quetelet index is a value derived from the mass (weight) 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04049695 - Improving Cognition After Cancer N/A
Completed NCT03696056 - Improving Brain Function After Breast Cancer Study N/A
Recruiting NCT06073717 - Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT). N/A
Active, not recruiting NCT00981305 - Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors Phase 3
Active, not recruiting NCT03674437 - Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
Active, not recruiting NCT05743023 - Consciousness-based Ayurveda Lifestyle Program for Improving Quality of Life in Survivors of Breast Cancer N/A
Completed NCT02062255 - Impact of COX2 on Sera Biomarkers From Obese Subjects Phase 0
Active, not recruiting NCT04262180 - Physical Activity Promotion for Breast and Endometrial Cancer Survivors N/A
Active, not recruiting NCT04883398 - A Study of Attention and Memory Processes in Breast Cancer Survivors
Completed NCT01217216 - Cancer Survival Through Weight Loss and Exercise N/A
Completed NCT05506189 - Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching Program
Recruiting NCT03644329 - Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors. N/A
Active, not recruiting NCT02726763 - Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training N/A
Completed NCT05690295 - Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer N/A
Recruiting NCT06334354 - A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
Completed NCT02753985 - Adherence to Aromatase Inhibitors: The Role of Partners
Active, not recruiting NCT04818359 - Movement and Health Beyond Care (MoviS) N/A
Completed NCT05203029 - Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety/Depression Levels in Breast Cancer N/A
Recruiting NCT05848141 - Rowing Following Breast Cancer Chemotherapy N/A
Completed NCT02672189 - Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms Phase 3